An omega-3 paradox: When 'healthy fats' shut down defenses against cancer

Weekly cisplatin shows similar burden of acute treatment side effects as every 3-week schedule for patients with p16-negative head and neck cancer on NRG oncology trial

Cell paper identifies subclusters driving cancer-induced cachexia

A new chapter in targeting kinase enzymes in cancer